drug

Lifestyle Intervention

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

BEHAVIORAL

Pre-approval / investigational in the US

Developed by Centre for Addiction and Mental Health

2 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

BEHAVIORAL

Indications

Investigational (via trials)

Schizophrenia Type 2 Diabetes Mellitus Substance-induced Psychosis Bipolar Disorder Schizophreniform Disorder Mental Disorders Schizophrenia Depressive Disorder, Major Severe Mental Disorder Major Depressive Disorder Overweight and/or Obesity Severe Mental Illness Psychotic Disorders Cardio Vascular Disease Bipolar Disease Type I Cardiovascular Diseases

Trials

Norwegian Mental Illness Heart Health Study

NCT07085923—Recruiting

Lifestyle Intervention for Diabetes and Weight Management in Psychosis

NCT01828931—Completed

KOLs & investigators

Margaret McNamara McClure, Ph.D.KOL score 5

Professor Kjetil Retterstøl, Professor, MD

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Centre for Addiction and Mental Health

company

trial

Norwegian Mental Illness Heart Health Study

trial

Lifestyle Intervention for Diabetes and Weight Management in Psychosis

trial

indication

Schizophrenia

indication

Type 2 Diabetes Mellitus

indication

Substance-induced Psychosis

indication

Bipolar Disorder

indication

KOL

Margaret McNamara McClure, Ph.D.

KOL score 5

person

Professor Kjetil Retterstøl, Professor, MD

KOL score —

person